… Could plasma collected from COVID-19 convalescent patients be efficacious in treating
patients still battling the infection, or as a prophylactic approach to prevent this disease? In this …

… Our group has successfully identified seven patients with SARS-CoV-2 infection from 148 …
antibody titers in eight convalescent patients with COVID-19, four patients showed decreased …

… syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes coronavirus disease 2019
(… ongoing clinical trials on convalescent plasma therapy in pediatric patients with COVID-19. …

… viable SARS-CoV from the urine of a convalescent patient has not been reported previously.
Our isolation of living SARS-CoV from the stool specimens of convalescent SARS patients …

… Convalescent plasma is safe, does not improve survival, has … the respiratory tract, influence
SARS-CoV-2 antibody development … of patients already had potent neutralizing SARS-CoV-2 …

Long-term antibody responses and neutralizing activities in response to SARS-CoV-2
infection are not yet clear. Here we quantify immunoglobulin M (IgM) and G (IgG) antibodies …

… Management with convalescent plasma for treating the SARS patients resulted in reduced
hospital stay and decreased mortality. Following the administration of this plasma, no acute …

… optimal convalescent plasma donors. The aim of this study was to characterize SARS-CoV-2 …
and convalescent patients, and compare their association with neutralizing antibody titers. …

… parallel efforts using both humanized mice and convalescent patients to generate antibodies
against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein, …

… They also reported that sera from several patients could inhibit SARS-CoV-2 entry in target
cells, indicating involvement of humoral immunity. Krammer and colleagues detected anti-S …